Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005289 |
---|---|
Receipt number | R000006290 |
Scientific Title | Phase 1 study of neoadjuvant chemotherapy with capecitabine/bevacizumab for locally advanced lower rectal cancer. |
Date of disclosure of the study information | 2011/03/22 |
Last modified on | 2015/03/23 17:33:09 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/22 22:04:32 | ||
2 | Update | 2011/10/24 09:50:44 | Last name of contact person Last name of contact person Organization Organization Division name Division name TEL Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Tel1 Email1 |
|
3 | Update | 2013/03/25 09:50:59 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete |
|
4 | Update | 2014/02/04 09:11:22 | Email |
|
5 | Update | 2015/03/23 17:32:34 | Recruitment status |
|
6 | Update | 2015/03/23 17:33:09 | Publication of results |